Corpus Intelligence IC Memo — PEACE HAVEN ASSOCIATION 2026-04-27 03:58 UTC
IC Memo — PEACE HAVEN ASSOCIATION
Investment Committee Memorandum | MO | 14 beds | Grade D | EBITDA uplift $120K
🛡️ Public data only — no PHI permitted on this instance.
INVESTMENT COMMITTEE MEMORANDUM  ·  CCN 261993

PEACE HAVEN ASSOCIATION

LOCATIONST. LOUIS, MO·BEDS14·AS OFApril 27, 2026
D
INVESTABILITY
EBITDA BridgeData Room

1. Target Overview & Investment Thesis

PEACE HAVEN ASSOCIATION is a 14-bed community hospital in ST. LOUIS, MO with $1.4M in net patient revenue and a -100.0% operating margin. The hospital serves a payer mix of 5.1% Medicare, 0.0% Medicaid, and 94.9% commercial.

Thesis: Turnaround. Our ML models identify $120K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -100.0% to -104.6% (+851bps).

Net Revenue HCRIS$1.4M
Current EBITDA COMPUTED$-1.6M
Operating Margin COMPUTED-100.0%
Occupancy HCRIS68.0%
Revenue / Bed COMPUTED$101K
Net-to-Gross HCRIS99.7%
Distress Probability MLnan%

2. Market Context & Competitive Position

138
MO Hospitals
-6.2%
State Median Margin
38
Comparable Hospitals

MO has 138 Medicare-certified hospitals with a median operating margin of -6.2%. The target's margin of -100.0% places it below the state median. Among 38 size-comparable peers (7-28 beds), the median margin is -9.3%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (7-28), prioritizing same-state peers. 38 hospitals in the comp set.

HospitalStateBedsRevenueMargin
PEACE HAVEN ASSOCIATION (Target)MO14$1.4M-100.0%
CASS REGIONAL MEDICAL CENTERMO25$89.9M5.4%
MISSOURI BAPTIST SULLIVAN HOSPMO25$73.4M2.7%
HEDRICK MEDICAL CENTERMO25$63.8M5.4%
COX-MONETT HOSPITALMO25$63.8M8.2%
STE. GENEVIEVE CO. MEMORIAL HOMO25$61.0M-6.8%
PERRY COUNTY MEMORIAL HOSPITALMO25$60.8M-9.3%
MERCY HOSPITAL CARTHAGEMO25$58.4M7.9%
EXCELSIOR SPRINGS HOSPITALMO25$44.0M-5.8%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $120K (851bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Denial Rate Reduction12.0%6.5%$35K+251bp12mo
Net Collection Rate93.5%97.0%$30K+210bp18mo
Cost to Collect4.5%2.5%$28K+200bp12mo
A/R Days Reduction5200.0%3800.0%$17K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+68bp6mo

5. EBITDA Bridge

Denial Rate Reduction
$35K
Net Collection Rate
$30K
Cost to Collect
$28K
A/R Days Reduction
$17K
Clean Claim Rate
$10K
Total EBITDA Uplift$120K
Current EBITDA$-1.6M
+ RCM Uplift+$120K
Pro Forma EBITDA$-1.5M
Current Margin-100.0%
Pro Forma Margin-104.6%
WC Released (1x)$54K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-2.5M$-9.3M0.00x-100.0%
Base (11x exit)10.0x11.0x$-2.5M$-11.0M0.00x-100.0%
Bull Case9.0x11.0x$-2.2M$-11.4M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-2.2M$-13.1M0.00x-100.0%
Bear Case11.0x10.0x$-2.7M$-9.1M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-2.7M$-10.9M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 38 hospitals with 7-28 beds
  • Same-state prioritization (n=39)
  • Comp margins: P25=-17.3% / P50=-9.3% / P75=-0.3%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 27, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.